The Role of miRNAs and Epigenetic Factors in Non-Alcoholic Fatty Liver Disease - a Systematic Review.

Current health sciences journal Pub Date : 2025-01-01 Epub Date: 2025-03-31 DOI:10.12865/CHSJ.51.01.04
Victor Constantin Stoica, Mihai Mircea Diculescu, Mircea Mănuc, Ileana Constantinescu, Iuliana Petronela Gârdan, Adrian Daniel Gârdan
{"title":"The Role of miRNAs and Epigenetic Factors in Non-Alcoholic Fatty Liver Disease - a Systematic Review.","authors":"Victor Constantin Stoica, Mihai Mircea Diculescu, Mircea Mănuc, Ileana Constantinescu, Iuliana Petronela Gârdan, Adrian Daniel Gârdan","doi":"10.12865/CHSJ.51.01.04","DOIUrl":null,"url":null,"abstract":"<p><p>Non-alcoholic liver disease is affecting approximately a quarter of the global population, with a significant morbidity and mortality rate. The present paper takes into discussion a systematic review of the literature concerning the role that microRNAs (miRNAs) and epigenetic factors can have in relation with NAFLD. Using PRISMA methodology guidelines, the systematic review offers a comprehensive image of the relevant scientific literature that explains the complex role of miRNAs in relation with NAFLD. Throughout the process of reviewing there has been highlighted seven different subtopics that can synthetize the nature and the content of the different studies: the role of miRNAs in fibrosis and liver disease progression; use of microRNAs as biomarkers for diagnosing steatotic liver disease; microRNAs and targeted therapies for NAFLD (Nonalcoholic fatty liver disease) /NASH (Non-alcoholic Steatohepatitis); metabolic regulation and obesity via microRNAs; interaction of miRNAs with other factors at the molecular level in disease pathogenesis; the role of miRNAs in systemic inflammation and effects on various other organs and the role of miRNAs as regulators and highly specialized epigenetic factors affecting NAFLD pathogenesis and evolution. Overall, this review presents diverse approaches on microRNAs and gives a background for future applied research that can explain and test their potential as biomarkers for diagnosing and understanding disease mechanisms, particularly in populations exposed to historical nutritional imbalances.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"51 1","pages":"37-52"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12265002/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current health sciences journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12865/CHSJ.51.01.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/31 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Non-alcoholic liver disease is affecting approximately a quarter of the global population, with a significant morbidity and mortality rate. The present paper takes into discussion a systematic review of the literature concerning the role that microRNAs (miRNAs) and epigenetic factors can have in relation with NAFLD. Using PRISMA methodology guidelines, the systematic review offers a comprehensive image of the relevant scientific literature that explains the complex role of miRNAs in relation with NAFLD. Throughout the process of reviewing there has been highlighted seven different subtopics that can synthetize the nature and the content of the different studies: the role of miRNAs in fibrosis and liver disease progression; use of microRNAs as biomarkers for diagnosing steatotic liver disease; microRNAs and targeted therapies for NAFLD (Nonalcoholic fatty liver disease) /NASH (Non-alcoholic Steatohepatitis); metabolic regulation and obesity via microRNAs; interaction of miRNAs with other factors at the molecular level in disease pathogenesis; the role of miRNAs in systemic inflammation and effects on various other organs and the role of miRNAs as regulators and highly specialized epigenetic factors affecting NAFLD pathogenesis and evolution. Overall, this review presents diverse approaches on microRNAs and gives a background for future applied research that can explain and test their potential as biomarkers for diagnosing and understanding disease mechanisms, particularly in populations exposed to historical nutritional imbalances.

mirna和表观遗传因子在非酒精性脂肪性肝病中的作用——系统综述
非酒精性肝病影响着全球约四分之一的人口,发病率和死亡率很高。本文对有关microRNAs (miRNAs)和表观遗传因素在NAFLD中的作用的文献进行了系统的综述。使用PRISMA方法学指南,系统综述提供了相关科学文献的全面图像,解释了mirna在NAFLD中的复杂作用。在整个回顾过程中,突出了七个不同的子主题,可以综合不同研究的性质和内容:mirna在纤维化和肝脏疾病进展中的作用;使用microrna作为诊断脂肪变性肝病的生物标志物;NAFLD(非酒精性脂肪性肝病)/NASH(非酒精性脂肪性肝炎)的microrna和靶向治疗通过microrna调控代谢和肥胖;miRNAs在分子水平上与其他因素在疾病发病中的相互作用;mirna在全身性炎症中的作用及其对其他器官的影响,以及mirna作为影响NAFLD发病和进化的调节因子和高度特化的表观遗传因子的作用。总的来说,本文综述了microrna的多种研究方法,并为未来的应用研究提供了背景,这些研究可以解释和测试microrna作为诊断和理解疾病机制的生物标志物的潜力,特别是在暴露于历史营养失衡的人群中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信